Holen Sie sich die Stockscreener-App
5.105
1.10%
-0.055
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
BNP Paribas Financial Markets Makes New $1.13 Million Investment in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High? - MSN
Olema Oncology Advances Cancer Trials with Strong Financials - TipRanks
Olema Oncology to Participate in Upcoming Investor Conferences | - GuruFocus
Olema Oncology to Participate in Upcoming Investor Conferences | OLMA Stock News - GuruFocus
Olema Oncology to Participate in Upcoming Investor Conferences - GlobeNewswire
Breast Cancer Biotech Olema Sets Major Presentations at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan
Paradigm Biocapital Advisors LP Purchases 1,801,370 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Bought by MPM Bioimpact LLC - MarketBeat
Price T Rowe Associates Inc. MD Has $153,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
The Goldman Sachs Group Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $18.00 - Defense World
Oppenheimer Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $22.00 - Defense World
Q2 EPS Estimate for Olema Pharmaceuticals Raised by Analyst - Defense World
Voya Investment Management LLC Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Driehaus Capital Management LLC Takes $1.28 Million Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Analysts Offer Insights on Healthcare Companies: Astria Therapeutics (ATXS), Aquestive Therapeutics (AQST) and Olema Pharmaceuticals (OLMA) - The Globe and Mail
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth - Yahoo Finance
Olema Pharmaceuticals (OLMA) Price Target Lowered by Oppenheimer - GuruFocus
Balyasny Asset Management L.P. Increases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals (OLMA) Price Target Lowered by Goldman Sachs | OLMA Stock News - GuruFocus
Olema Oncology (OLMA) Price Target Adjusted Amid Upcoming Data R - GuruFocus
Lightspeed Management Company L.L.C. Makes New Investment in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Oncology (OLMA) Pushes Forward with Promising Cancer Treat - GuruFocus
Olema Oncology (OLMA) Pushes Forward with Promising Cancer Treatments | OLMA Stock News - GuruFocus
Olema Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Olema Oncology Reports First Quarter 2025 Financial and Operating Results - The Manila Times
Olema Oncology Strengthens Breast Cancer Pipeline: Key Phase 3 Trial Updates and $392M War Chest - Stock Titan
Hsbc Holdings PLC Invests $58,000 in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals (OLMA) Projected to Post Earnings on Wednesday - MarketBeat
Deep Track Capital LP Decreases Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Dimensional Fund Advisors LP Cuts Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Wells Fargo & Company MN Raises Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by BVF Inc. IL - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Barclays PLC - Defense World
Boxer Capital Management LLC Takes Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Market Insight: Olema Pharmaceuticals Inc (OLMA)’s Notable Drop, Closing at 4.60 - DWinneX
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Acquired by Renaissance Technologies LLC - MarketBeat
HC Wainwright Reaffirms Buy Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat
17.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):